Molecules 2013, 18(3), 3379-3409; doi:10.3390/molecules18033379
Review

Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases

Department of Nuclear Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany
* Author to whom correspondence should be addressed.
Received: 29 December 2012; in revised form: 25 February 2013 / Accepted: 7 March 2013 / Published: 14 March 2013
(This article belongs to the Special Issue Chemical Protein and Peptide Synthesis)
PDF Full-text Download PDF Full-Text [540 KB, uploaded 14 March 2013 09:42 CET]
Abstract: Despite the advances in molecular biology and biochemistry, the prognosis of patients suffering from tumor diseases remains poor. The limited therapeutic success can be explained by the insufficient performance of the common chemotherapeutic drugs that lack the ability to specifically target tumor tissues. Recently peptide radiopharmaceuticals have been developed that enable the concurrent imaging and therapy of tumors expressing a specific target. Here, with a special emphasis on the synthesis of the building blocks required for the complexation of metallic radioisotopes, the requirements to the design and synthesis of radiolabeled peptides for clinical applications are described.
Keywords: radionuclides; chelator; prosthetic groups; carrier molecules; peptides; medicinal application; radiopharmaceutical; diagnostic imaging; radiotherapeutics

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Jamous, M.; Haberkorn, U.; Mier, W. Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases. Molecules 2013, 18, 3379-3409.

AMA Style

Jamous M, Haberkorn U, Mier W. Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases. Molecules. 2013; 18(3):3379-3409.

Chicago/Turabian Style

Jamous, Mazen; Haberkorn, Uwe; Mier, Walter. 2013. "Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases." Molecules 18, no. 3: 3379-3409.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert